SGCG and asthma: Accumulated evidence from numerous studies has reported that the innate antiviral immune response (including type I and type III interferons) in asthma patients is less effective or deficient, leading to the conclusion that epithelial innate immunity is a crucial determinant of severe disease during RV-induced asthma exacerbation.